BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1400521 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)C(=O)c1noc(=O)[nH]1 |(7.73,2.82,;6.23,3.14,;5.75,4.61,;4.24,4.93,;3.21,3.78,;3.69,2.32,;2.66,1.17,;5.2,2,;5.67,.53,;7.14,.06,;7.14,-1.48,;5.67,-1.96,;5.2,-3.42,;4.05,-4.45,;5.52,-4.93,;4.77,-.71,;3.23,-.71,;2.46,-2.05,;.92,-2.05,;.15,-3.38,;-1.39,-3.38,;-2.16,-2.05,;-1.39,-.71,;.15,-.71,;-3.7,-2.05,;-4.47,-3.38,;-4.47,-.71,;-3.85,.7,;-4.99,1.73,;-6.33,.96,;-7.73,1.58,;-6.01,-.55,)| InChI=1S/C21H20Cl2N4O5/c22-14-2-1-3-15(23)16(14)17-13(18(31-25-17)11-4-5-11)10-30-12-6-8-27(9-7-12)20(28)19-24-21(29)32-26-19/h1-3,11-12H,4-10H2,(H,24,26,29) RUJJJOUHGMTUGW-UHFFFAOYSA-N 665622 US20240116912, Example 1::3-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidine-1-carbonyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3184 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665622 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665622&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902531 497615788 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400522 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)C1=NN1 |t:35,(3.2,1.59,;3.97,2.92,;3.2,4.25,;3.97,5.59,;5.51,5.59,;6.28,4.25,;7.82,4.25,;5.51,2.92,;6.28,1.59,;7.81,1.42,;8.13,-.08,;6.8,-.85,;6.4,-2.34,;5.31,-3.43,;6.8,-3.83,;5.65,.18,;4.17,-.22,;3.77,-1.71,;2.28,-2.11,;1.19,-1.02,;-.3,-1.42,;-.69,-2.9,;.39,-3.99,;1.88,-3.59,;-2.18,-3.3,;-3.27,-2.21,;-4.76,-2.61,;-5.16,-4.1,;-4.07,-5.19,;-2.58,-4.79,;-6.64,-4.5,;-7.73,-5.59,;-8.13,-4.1,)| InChI=1S/C25H24Cl2N4O2/c26-20-2-1-3-21(27)22(20)23-19(24(33-30-23)15-4-5-15)14-32-18-10-12-31(13-11-18)17-8-6-16(7-9-17)25-28-29-25/h1-3,6-9,15,18H,4-5,10-14H2,(H,28,29) RWILOPMEHSRDHC-UHFFFAOYSA-N 665623 US20240116912, Example 2::4-(((1-(4-(1H-diazirin-3-yl)phenyl)piperidin-4-yl)oxy)methyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazole RNA-binding protein FXR1 [244-476] Homo sapiens 2885 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665623 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665623&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566703 497615789 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400523 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(4.37,1.76,;5.14,3.09,;4.37,4.43,;5.14,5.76,;6.68,5.76,;7.45,4.43,;8.99,4.43,;6.68,3.09,;7.45,1.76,;8.98,1.6,;9.3,.09,;7.97,-.68,;7.57,-2.16,;6.48,-3.25,;7.97,-3.65,;6.82,.35,;5.33,-.05,;4.94,-1.53,;3.45,-1.93,;2.36,-.84,;.87,-1.24,;.47,-2.73,;1.56,-3.82,;3.05,-3.42,;-1.01,-3.13,;-2.1,-2.04,;-3.59,-2.44,;-3.99,-3.92,;-2.9,-5.01,;-1.41,-4.61,;-5.48,-4.32,;-6.03,-5.76,;-7.57,-5.68,;-7.97,-4.19,;-9.3,-3.42,;-6.67,-3.35,)| InChI=1S/C26H24Cl2N4O4/c27-20-2-1-3-21(28)22(20)23-19(24(35-30-23)15-4-5-15)14-34-18-10-12-32(13-11-18)17-8-6-16(7-9-17)25-29-26(33)36-31-25/h1-3,6-9,15,18H,4-5,10-14H2,(H,29,31,33) DKLAMHSJRAFGNM-UHFFFAOYSA-N 665624 US20240116912, Example 3::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3.60 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665624 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665624&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902532 497615790 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400524 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-n1c(=O)cn[nH]c1=O |(3.94,2.33,;4.71,3.66,;3.94,5,;4.71,6.33,;6.25,6.33,;7.02,5,;8.56,5,;6.25,3.66,;7.02,2.33,;8.56,2.17,;8.88,.66,;7.54,-.11,;7.14,-1.6,;6.05,-2.68,;7.54,-3.08,;6.4,.92,;4.91,.52,;4.51,-.96,;3.02,-1.36,;1.94,-.27,;.45,-.67,;.05,-2.16,;1.14,-3.25,;2.63,-2.85,;-1.44,-2.56,;-2.53,-1.47,;-4.01,-1.87,;-4.41,-3.36,;-3.32,-4.44,;-1.84,-4.05,;-5.9,-3.75,;-6.99,-2.66,;-6.59,-1.18,;-8.48,-3.06,;-8.88,-4.55,;-7.79,-5.64,;-6.3,-5.24,;-5.21,-6.33,)| InChI=1S/C26H24Cl2N6O4/c27-19-2-1-3-20(28)23(19)24-18(25(38-32-24)15-4-5-15)14-37-17-8-10-33(11-9-17)21-7-6-16(12-29-21)34-22(35)13-30-31-26(34)36/h1-3,6-7,12-13,15,17H,4-5,8-11,14H2,(H,31,36) UCXFCKVQGZGZQN-UHFFFAOYSA-N 665625 US20240116912, Example 4::4-(6-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)-1,2,4-triazine-3, 5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 220 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665625 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665625&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902533 497615791 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400525 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ncc(cn1)-c1noc(=O)[nH]1 |(4.37,1.76,;5.14,3.09,;4.37,4.43,;5.14,5.76,;6.68,5.76,;7.45,4.43,;8.99,4.43,;6.68,3.09,;7.45,1.76,;8.98,1.6,;9.3,.09,;7.97,-.68,;7.57,-2.16,;6.48,-3.25,;7.97,-3.65,;6.82,.35,;5.33,-.05,;4.94,-1.53,;3.45,-1.93,;2.36,-.84,;.87,-1.24,;.47,-2.73,;1.56,-3.82,;3.05,-3.42,;-1.01,-3.13,;-2.1,-2.04,;-3.59,-2.44,;-3.99,-3.92,;-2.9,-5.01,;-1.41,-4.61,;-5.48,-4.32,;-6.03,-5.76,;-7.57,-5.68,;-7.97,-4.19,;-9.3,-3.42,;-6.67,-3.35,)| InChI=1S/C24H22Cl2N6O4/c25-17-2-1-3-18(26)19(17)20-16(21(35-30-20)13-4-5-13)12-34-15-6-8-32(9-7-15)23-27-10-14(11-28-23)22-29-24(33)36-31-22/h1-3,10-11,13,15H,4-9,12H2,(H,29,31,33) BNOCUBYTUXPQBL-UHFFFAOYSA-N 665626 US20240116912, Example 5::3-(2-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyrimidin-5-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 31.0 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665626&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902534 497615792 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400526 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1noc(=O)[nH]1 |(4.37,1.76,;5.14,3.09,;4.37,4.43,;5.14,5.76,;6.68,5.76,;7.45,4.43,;8.99,4.43,;6.68,3.09,;7.45,1.76,;8.98,1.6,;9.3,.09,;7.97,-.68,;7.57,-2.16,;6.48,-3.25,;7.97,-3.65,;6.82,.35,;5.33,-.05,;4.94,-1.53,;3.45,-1.93,;2.36,-.84,;.87,-1.24,;.47,-2.73,;1.56,-3.82,;3.05,-3.42,;-1.01,-3.13,;-2.1,-2.04,;-3.59,-2.44,;-3.99,-3.92,;-2.9,-5.01,;-1.41,-4.61,;-5.48,-4.32,;-6.03,-5.76,;-7.57,-5.68,;-7.97,-4.19,;-9.3,-3.42,;-6.67,-3.35,)| InChI=1S/C25H23Cl2N5O4/c26-18-2-1-3-19(27)21(18)22-17(23(35-30-22)14-4-5-14)13-34-16-8-10-32(11-9-16)20-7-6-15(12-28-20)24-29-25(33)36-31-24/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,29,31,33) PCCAYOJLQWEMQA-UHFFFAOYSA-N 665627 US20240116912, Example 6::3-(6-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 4.40 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665627&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902535 497615793 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400527 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1cccc(c1)-c1noc(=O)[nH]1 |(3.17,1.39,;3.94,2.72,;3.17,4.05,;3.94,5.39,;5.48,5.39,;6.25,4.05,;7.79,4.05,;5.48,2.72,;6.25,1.39,;7.78,1.23,;8.1,-.28,;6.77,-1.05,;6.37,-2.54,;5.28,-3.63,;6.77,-4.03,;5.62,-.02,;4.13,-.42,;3.74,-1.91,;2.25,-2.31,;1.16,-1.22,;-.33,-1.62,;-.73,-3.1,;.36,-4.19,;1.85,-3.79,;-2.21,-3.5,;-2.61,-4.99,;-4.1,-5.39,;-5.19,-4.3,;-4.79,-2.81,;-3.3,-2.41,;-5.88,-1.72,;-7.4,-1.96,;-8.1,-.59,;-7.01,.5,;-7.41,1.99,;-5.64,-.2,)| InChI=1S/C26H24Cl2N4O4/c27-20-5-2-6-21(28)22(20)23-19(24(35-30-23)15-7-8-15)14-34-18-9-11-32(12-10-18)17-4-1-3-16(13-17)25-29-26(33)36-31-25/h1-6,13,15,18H,7-12,14H2,(H,29,31,33) BUPROQYFCLKBTG-UHFFFAOYSA-N 665628 US20240116912, Example 7::3-(3-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 105 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665628&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902536 497615794 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400528 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1cnc(nc1)-c1noc(=O)[nH]1 |(4.37,1.76,;5.14,3.09,;4.37,4.43,;5.14,5.76,;6.68,5.76,;7.45,4.43,;8.99,4.43,;6.68,3.09,;7.45,1.76,;8.98,1.6,;9.3,.09,;7.97,-.68,;7.57,-2.16,;6.48,-3.25,;7.97,-3.65,;6.82,.35,;5.33,-.05,;4.94,-1.53,;3.45,-1.93,;2.36,-.84,;.87,-1.24,;.47,-2.73,;1.56,-3.82,;3.05,-3.42,;-1.01,-3.13,;-2.1,-2.04,;-3.59,-2.44,;-3.99,-3.92,;-2.9,-5.01,;-1.41,-4.61,;-5.48,-4.32,;-6.03,-5.76,;-7.57,-5.68,;-7.97,-4.19,;-9.3,-3.42,;-6.67,-3.35,)| InChI=1S/C24H22Cl2N6O4/c25-17-2-1-3-18(26)19(17)20-16(21(35-30-20)13-4-5-13)12-34-15-6-8-32(9-7-15)14-10-27-22(28-11-14)23-29-24(33)36-31-23/h1-3,10-11,13,15H,4-9,12H2,(H,29,31,33) NAJSEBBGFSFCIA-UHFFFAOYSA-N 665629 US20240116912, Example 8::3-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyrimidin-2-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 28.1 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665629&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902537 497615795 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400529 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(nc1)-c1noc(=O)[nH]1 |(4.37,1.76,;5.14,3.09,;4.37,4.43,;5.14,5.76,;6.68,5.76,;7.45,4.43,;8.99,4.43,;6.68,3.09,;7.45,1.76,;8.98,1.6,;9.3,.09,;7.97,-.68,;7.57,-2.16,;6.48,-3.25,;7.97,-3.65,;6.82,.35,;5.33,-.05,;4.94,-1.53,;3.45,-1.93,;2.36,-.84,;.87,-1.24,;.47,-2.73,;1.56,-3.82,;3.05,-3.42,;-1.01,-3.13,;-2.1,-2.04,;-3.59,-2.44,;-3.99,-3.92,;-2.9,-5.01,;-1.41,-4.61,;-5.48,-4.32,;-6.03,-5.76,;-7.57,-5.68,;-7.97,-4.19,;-9.3,-3.42,;-6.67,-3.35,)| InChI=1S/C25H23Cl2N5O4/c26-18-2-1-3-19(27)21(18)22-17(23(35-30-22)14-4-5-14)13-34-16-8-10-32(11-9-16)15-6-7-20(28-12-15)24-29-25(33)36-31-24/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,29,31,33) SZRWGMHOBDOUTB-UHFFFAOYSA-N 665630 US20240116912, Example 9::3-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-2-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 175 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665630&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902538 497615796 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400530 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1n[nH]c(=O)[nH]c1=O |(4.69,1.98,;5.46,3.32,;4.69,4.65,;5.46,5.99,;7,5.99,;7.77,4.65,;9.31,4.65,;7,3.32,;7.77,1.98,;9.3,1.82,;9.62,.32,;8.29,-.45,;7.89,-1.94,;6.8,-3.03,;8.29,-3.43,;7.14,.58,;5.65,.18,;5.26,-1.31,;3.77,-1.71,;2.68,-.62,;1.19,-1.02,;.79,-2.5,;1.88,-3.59,;3.37,-3.19,;-.69,-2.9,;-1.78,-1.81,;-3.27,-2.21,;-3.67,-3.7,;-2.58,-4.79,;-1.09,-4.39,;-5.16,-4.1,;-5.56,-5.59,;-7.04,-5.99,;-8.13,-4.9,;-9.62,-5.29,;-7.73,-3.41,;-6.25,-3.01,;-5.85,-1.52,)| InChI=1S/C27H25Cl2N5O4/c28-20-2-1-3-21(29)22(20)24-19(25(38-33-24)16-4-5-16)14-37-18-10-12-34(13-11-18)17-8-6-15(7-9-17)23-26(35)30-27(36)32-31-23/h1-3,6-9,16,18H,4-5,10-14H2,(H2,30,32,35,36) VGCPGKGCHMDPSV-UHFFFAOYSA-N 665631 US20240116912, Example 10::6-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-triazine-3,5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 9.10 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665631&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902539 497615797 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400531 Cc1cc(ccc1-c1noc(=O)[nH]1)N1CCC(CC1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |(6.26,1.47,;5.17,.38,;3.69,.78,;2.6,-.31,;3,-1.8,;4.48,-2.2,;5.57,-1.11,;7.06,-1.51,;8.31,-.6,;9.55,-1.51,;9.07,-2.97,;9.84,-4.31,;7.53,-2.97,;1.11,.09,;.02,-1,;-1.47,-.6,;-1.87,.89,;-.78,1.97,;.71,1.58,;-3.35,1.28,;-4.44,.19,;-5.93,.59,;-6.41,2.06,;-7.95,2.06,;-8.42,.59,;-7.18,-.31,;-7.18,-1.85,;-8.51,-2.62,;-9.84,-1.85,;-8.51,-4.16,;-7.18,-4.93,;-5.84,-4.16,;-5.84,-2.62,;-4.51,-1.85,;-5.64,3.39,;-4.3,4.16,;-5.64,4.93,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-17(7-8-19(15)26-30-27(34)37-32-26)33-11-9-18(10-12-33)35-14-20-24(31-36-25(20)16-5-6-16)23-21(28)3-2-4-22(23)29/h2-4,7-8,13,16,18H,5-6,9-12,14H2,1H3,(H,30,32,34) FDQKPQYJCQBOMJ-UHFFFAOYSA-N 665632 US20240116912, Example 11::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-2-methylphenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 21.9 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665632&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902540 497615798 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400532 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1n[nH]c(=O)o1 |(4.37,1.76,;5.14,3.09,;4.37,4.43,;5.14,5.76,;6.68,5.76,;7.45,4.43,;8.99,4.43,;6.68,3.09,;7.45,1.76,;8.98,1.6,;9.3,.09,;7.97,-.68,;7.57,-2.16,;6.48,-3.25,;7.97,-3.65,;6.82,.35,;5.33,-.05,;4.94,-1.53,;3.45,-1.93,;2.36,-.84,;.87,-1.24,;.47,-2.73,;1.56,-3.82,;3.05,-3.42,;-1.01,-3.13,;-2.1,-2.04,;-3.59,-2.44,;-3.99,-3.92,;-2.9,-5.01,;-1.41,-4.61,;-5.48,-4.32,;-6.03,-5.76,;-7.57,-5.68,;-7.97,-4.19,;-9.3,-3.42,;-6.67,-3.35,)| InChI=1S/C26H24Cl2N4O4/c27-20-2-1-3-21(28)22(20)23-19(24(36-31-23)15-4-5-15)14-34-18-10-12-32(13-11-18)17-8-6-16(7-9-17)25-29-30-26(33)35-25/h1-3,6-9,15,18H,4-5,10-14H2,(H,30,33) RZSNDHNBQQQESY-UHFFFAOYSA-N 665633 US20240116912, Example 12::5-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 73.7 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665633 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665633&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566807 497615799 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400533 Fc1cc(ccc1-c1noc(=O)[nH]1)N1CCC(CC1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |(6.26,1.47,;5.17,.38,;3.69,.78,;2.6,-.31,;3,-1.8,;4.48,-2.2,;5.57,-1.11,;7.06,-1.51,;8.31,-.6,;9.55,-1.51,;9.07,-2.97,;9.84,-4.31,;7.53,-2.97,;1.11,.09,;.02,-1,;-1.47,-.6,;-1.87,.89,;-.78,1.97,;.71,1.58,;-3.35,1.28,;-4.44,.19,;-5.93,.59,;-6.41,2.06,;-7.95,2.06,;-8.42,.59,;-7.18,-.31,;-7.18,-1.85,;-8.51,-2.62,;-9.84,-1.85,;-8.51,-4.16,;-7.18,-4.93,;-5.84,-4.16,;-5.84,-2.62,;-4.51,-1.85,;-5.64,3.39,;-4.3,4.16,;-5.64,4.93,)| InChI=1S/C26H23Cl2FN4O4/c27-19-2-1-3-20(28)22(19)23-18(24(36-31-23)14-4-5-14)13-35-16-8-10-33(11-9-16)15-6-7-17(21(29)12-15)25-30-26(34)37-32-25/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,30,32,34) SZUTZPIRLJSLMT-UHFFFAOYSA-N 665634 US20240116912, Example 13::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-2-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3.50 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665634&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902541 497615800 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400534 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(-c2noc(=O)[nH]2)c(Cl)c1 |(-9.84,-1.85,;-8.51,-2.62,;-8.51,-4.16,;-7.18,-4.93,;-5.84,-4.16,;-5.84,-2.62,;-4.51,-1.85,;-7.18,-1.85,;-7.18,-.31,;-8.42,.59,;-7.95,2.06,;-6.41,2.06,;-5.64,3.39,;-4.3,4.16,;-5.64,4.93,;-5.93,.59,;-4.44,.19,;-3.35,1.28,;-1.87,.89,;-1.47,-.6,;.02,-1,;1.11,.09,;.71,1.58,;-.78,1.97,;2.6,-.31,;3,-1.8,;4.48,-2.2,;5.57,-1.11,;7.06,-1.51,;8.31,-.6,;9.55,-1.51,;9.07,-2.97,;9.84,-4.31,;7.53,-2.97,;5.17,.38,;6.26,1.47,;3.69,.78,)| InChI=1S/C26H23Cl3N4O4/c27-19-2-1-3-20(28)22(19)23-18(24(36-31-23)14-4-5-14)13-35-16-8-10-33(11-9-16)15-6-7-17(21(29)12-15)25-30-26(34)37-32-25/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,30,32,34) PURFABARUHIOQE-UHFFFAOYSA-N 665635 US20240116912, Example 14::3-(2-chloro-4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 8.50 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665635 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665635&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902542 497615801 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400535 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(C1)c1ccc(cc1)-c1noc(=O)[nH]1 |(-8.22,-3.32,;-6.68,-3.32,;-5.91,-4.66,;-4.37,-4.66,;-3.6,-3.32,;-4.37,-1.99,;-3.6,-.66,;-5.91,-1.99,;-6.68,-.66,;-8.21,-.49,;-8.53,1.01,;-7.2,1.78,;-7.2,3.32,;-6.43,4.66,;-7.97,4.66,;-6.05,.75,;-4.56,1.15,;-4.17,2.64,;-2.68,3.04,;-2.03,4.43,;-.5,4.25,;-.21,2.74,;-1.55,1.99,;1.28,2.34,;2.37,3.43,;3.86,3.03,;4.26,1.54,;3.17,.45,;1.68,.85,;5.74,1.14,;6.99,2.05,;8.24,1.14,;7.76,-.32,;8.53,-1.66,;6.22,-.32,)| InChI=1S/C25H22Cl2N4O4/c26-19-2-1-3-20(27)21(19)22-18(23(34-29-22)14-4-5-14)13-33-17-10-11-31(12-17)16-8-6-15(7-9-16)24-28-25(32)35-30-24/h1-3,6-9,14,17H,4-5,10-13H2,(H,28,30,32) ZWZLSOMMRUZXGF-UHFFFAOYSA-N 665636 US20240116912, Example 15::3-(4-(3-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)pyrrolidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 892 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665636&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902543 497615802 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400536 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1cc(=O)[nH]o1 |(9.13,4.09,;7.59,4.09,;6.82,5.42,;5.28,5.42,;4.51,4.09,;5.28,2.75,;4.51,1.42,;6.82,2.75,;7.59,1.42,;9.12,1.26,;9.44,-.25,;8.11,-1.02,;7.95,-2.55,;7.04,-3.8,;8.58,-3.96,;6.97,.01,;5.46,-.31,;4.98,-1.77,;3.48,-2.09,;2.45,-.95,;.94,-1.27,;.47,-2.73,;1.5,-3.88,;3,-3.56,;-1.04,-3.05,;-2.07,-1.91,;-3.58,-2.23,;-4.05,-3.69,;-3.02,-4.84,;-1.52,-4.52,;-5.56,-4.01,;-6.7,-2.98,;-8.04,-3.75,;-9.44,-3.13,;-7.72,-5.26,;-6.19,-5.42,)| InChI=1S/C27H25Cl2N3O4/c28-21-2-1-3-22(29)25(21)26-20(27(36-31-26)17-4-5-17)15-34-19-10-12-32(13-11-19)18-8-6-16(7-9-18)23-14-24(33)30-35-23/h1-3,6-9,14,17,19H,4-5,10-13,15H2,(H,30,33) MAXXEFRDXYUJCL-UHFFFAOYSA-N 665637 US20240116912, Example 16::5-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)isoxazol-3(2H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 24.0 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665637&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566699 497615803 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400537 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-n1ncc(=O)[nH]c1=O |(5.05,.82,;5.92,2.09,;5.26,3.48,;6.13,4.75,;7.67,4.63,;8.33,3.24,;9.87,3.12,;7.46,1.97,;8.23,.64,;9.76,.46,;10.06,-1.06,;8.71,-1.81,;8.53,-3.34,;7.61,-4.57,;9.14,-4.75,;7.58,-.76,;6.07,-1.06,;5.34,-2.31,;3.8,-2.31,;3.03,-3.65,;1.49,-3.65,;.72,-2.31,;1.49,-.98,;3.03,-.98,;-.82,-2.31,;-1.59,-3.65,;-3.13,-3.65,;-3.9,-2.31,;-3.13,-.98,;-1.59,-.98,;-5.44,-2.31,;-6.21,-3.65,;-7.75,-3.65,;-8.52,-2.31,;-10.06,-2.31,;-7.75,-.98,;-6.21,-.98,;-5.44,.35,)| InChI=1S/C27H25Cl2N5O4/c28-21-2-1-3-22(29)24(21)25-20(26(38-32-25)16-4-5-16)15-37-19-10-12-33(13-11-19)17-6-8-18(9-7-17)34-27(36)31-23(35)14-30-34/h1-3,6-9,14,16,19H,4-5,10-13,15H2,(H,31,35,36) OVTXNXZXPHHAHI-UHFFFAOYSA-N 665638 US20240116912, Example 17::2-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-triazine-3, 5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 6067 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665638&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902544 497615804 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400538 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(-3.97,-3.47,;-4.74,-4.81,;-3.97,-6.14,;-4.74,-7.48,;-6.28,-7.48,;-7.05,-6.14,;-8.59,-6.14,;-6.28,-4.81,;-7.05,-3.47,;-8.58,-3.31,;-8.9,-1.81,;-7.57,-1.04,;-7.38,.49,;-8.02,1.9,;-6.48,1.74,;-6.42,-2.07,;-4.91,-1.75,;-4.43,-.28,;-2.93,.08,;-1.97,-1.12,;-.43,-1.12,;.53,.08,;.19,1.58,;-1.2,2.25,;-2.59,1.58,;1.37,2.56,;1.22,4.09,;2.46,5,;3.87,4.37,;4.03,2.84,;2.78,1.93,;5.08,5.32,;4.92,6.85,;6.33,7.48,;7.36,6.33,;8.9,6.33,;6.59,5,)| InChI=1S/C27H26Cl2N4O4/c28-21-4-1-5-22(29)23(21)24-20(25(36-31-24)16-6-7-16)15-35-19-3-2-13-33(14-12-19)18-10-8-17(9-11-18)26-30-27(34)37-32-26/h1,4-5,8-11,16,19H,2-3,6-7,12-15H2,(H,30,32,34) SYLGZVUWUCUIQE-UHFFFAOYSA-N 665639 US20240116912, Example 18::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)azepan-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 2.90 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665639&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902545 497615805 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400539 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CN(C1)c1ccc(cc1)-c1noc(=O)[nH]1 |(-4.05,-1.55,;-4.82,-2.89,;-4.05,-4.22,;-4.82,-5.56,;-6.36,-5.56,;-7.13,-4.22,;-8.67,-4.22,;-6.36,-2.89,;-7.13,-1.55,;-8.66,-1.39,;-8.98,.11,;-7.65,.88,;-7.46,2.41,;-8.1,3.82,;-6.56,3.66,;-6.5,-.15,;-4.99,.18,;-4.51,1.64,;-3.01,2,;-1.7,1.21,;-.9,2.52,;-2.21,3.32,;.59,2.92,;1.68,1.83,;3.17,2.23,;3.57,3.72,;2.48,4.81,;.99,4.41,;5.05,4.12,;5.6,5.56,;7.14,5.47,;7.54,3.99,;8.98,3.44,;6.25,3.15,)| InChI=1S/C24H20Cl2N4O4/c25-18-2-1-3-19(26)20(18)21-17(22(33-28-21)13-4-5-13)12-32-16-10-30(11-16)15-8-6-14(7-9-15)23-27-24(31)34-29-23/h1-3,6-9,13,16H,4-5,10-12H2,(H,27,29,31) GUVFORGJSBNIDC-UHFFFAOYSA-N 665640 US20240116912, Example 19::3-(4-(3-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)azetidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 122 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665640&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902546 497615806 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400540 C[C@H]1C[C@@H](CCN1c1ccc(cc1)-c1noc(=O)[nH]1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |r,wU:3.21,wD:1.0,(-.02,4.71,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-19(11-12-33(15)18-9-7-17(8-10-18)26-30-27(34)37-32-26)35-14-20-24(31-36-25(20)16-5-6-16)23-21(28)3-2-4-22(23)29/h2-4,7-10,15-16,19H,5-6,11-14H2,1H3,(H,30,32,34) ZENPCGXTVQPSAW-UHFFFAOYSA-N 665641 US20240116912, Example 20::3-(4-((2S,4R)-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 114 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665641&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902547 497615807 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400541 C[C@@H]1C[C@H](CCN1c1ccc(cc1)-c1noc(=O)[nH]1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |r,wU:1.0,wD:3.21,(-.02,4.71,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-19(11-12-33(15)18-9-7-17(8-10-18)26-30-27(34)37-32-26)35-14-20-24(31-36-25(20)16-5-6-16)23-21(28)3-2-4-22(23)29/h2-4,7-10,15-16,19H,5-6,11-14H2,1H3,(H,30,32,34) ZENPCGXTVQPSAW-UHFFFAOYSA-N 665642 US20240116912, Example 21::3-(4-((2R,4S)-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 79.3 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665642&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902548 497615808 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400542 C[C@H]1C[C@H](CCN1c1ccc(cc1)-c1noc(=O)[nH]1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |r,wD:3.21,1.0,(-.02,4.71,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-19(11-12-33(15)18-9-7-17(8-10-18)26-30-27(34)37-32-26)35-14-20-24(31-36-25(20)16-5-6-16)23-21(28)3-2-4-22(23)29/h2-4,7-10,15-16,19H,5-6,11-14H2,1H3,(H,30,32,34) ZENPCGXTVQPSAW-UHFFFAOYSA-N 665643 US20240116912, Example 22::3-(4-((2S,4S)-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 63.3 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665643&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902549 497615809 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400543 C[C@@H]1C[C@@H](CCN1c1ccc(cc1)-c1noc(=O)[nH]1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |r,wU:3.21,1.0,(-.02,4.71,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-19(11-12-33(15)18-9-7-17(8-10-18)26-30-27(34)37-32-26)35-14-20-24(31-36-25(20)16-5-6-16)23-21(28)3-2-4-22(23)29/h2-4,7-10,15-16,19H,5-6,11-14H2,1H3,(H,30,32,34) ZENPCGXTVQPSAW-UHFFFAOYSA-N 665644 US20240116912, Example 23::3-(4-((2R,4R)-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3.10 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665644 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665644&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902550 497615810 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400544 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-n1c(=O)[nH]nc(C#N)c1=O |(10.04,2.82,;8.54,3.17,;8.04,4.63,;6.53,4.92,;5.52,3.76,;6.02,2.3,;5,1.15,;7.53,2.01,;8.02,.55,;9.48,.07,;9.48,-1.47,;8.02,-1.95,;7.55,-3.41,;7.86,-4.92,;6.4,-4.43,;7.11,-.7,;5.57,-.7,;4.8,-2.03,;3.26,-2.03,;2.49,-3.37,;.95,-3.37,;.18,-2.03,;.95,-.7,;2.49,-.7,;-1.36,-2.04,;-2.13,-.71,;-3.67,-.71,;-4.44,-2.04,;-3.67,-3.37,;-2.13,-3.37,;-5.97,-2.03,;-6.74,-3.36,;-5.87,-4.63,;-8.28,-3.36,;-9.05,-2.03,;-8.31,-.65,;-9.08,.69,;-9.85,2.02,;-6.74,-.69,;-5.99,.65,)| InChI=1S/C28H24Cl2N6O4/c29-21-2-1-3-22(30)24(21)25-20(26(40-34-25)16-4-5-16)15-39-19-10-12-35(13-11-19)17-6-8-18(9-7-17)36-27(37)23(14-31)32-33-28(36)38/h1-3,6-9,16,19H,4-5,10-13,15H2,(H,33,38) HQNYEYHXUZZABT-UHFFFAOYSA-N 665645 US20240116912, Example 24::4-(4-(4-((5-cyclopropyl-3-(2,6- dichlorophenyl)isoxazol-4- yl)methoxy)piperidin-1-yl)phenyl)-3,5- dioxo-2,3,4,5-tetrahydro-1,2,4-triazine- 6-carbonitrile RNA-binding protein FXR1 [244-476] Homo sapiens 552 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665645 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665645&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902551 497615811 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400545 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-n1nc(C#N)c(=O)[nH]c1=O |(9.45,5.74,;7.91,5.74,;7.14,7.07,;5.6,7.07,;4.83,5.74,;5.6,4.41,;4.83,3.07,;7.14,4.41,;7.91,3.07,;9.44,2.91,;9.76,1.41,;8.43,.64,;8.27,-.9,;7.36,-2.14,;8.89,-2.3,;7.28,1.67,;5.78,1.35,;5.3,-.12,;3.8,-.44,;2.76,.71,;1.26,.39,;.78,-1.08,;1.81,-2.22,;3.32,-1.9,;-.72,-1.4,;-1.75,-.25,;-3.26,-.58,;-3.74,-2.04,;-2.71,-3.18,;-1.2,-2.86,;-5.24,-2.36,;-5.72,-3.82,;-7.24,-4.2,;-7.72,-5.66,;-8.19,-7.13,;-8.26,-3,;-9.76,-3.32,;-7.78,-1.54,;-6.27,-1.22,;-5.8,.25,)| InChI=1S/C28H24Cl2N6O4/c29-21-2-1-3-22(30)24(21)25-20(26(40-34-25)16-4-5-16)15-39-19-10-12-35(13-11-19)17-6-8-18(9-7-17)36-28(38)32-27(37)23(14-31)33-36/h1-3,6-9,16,19H,4-5,10-13,15H2,(H,32,37,38) CGOCGJWYILJMMI-UHFFFAOYSA-N 665646 US20240116912, Example 25::2-(4-(4-((5-cyclopropyl-3-(2,6- dichlorophenyl)isoxazol-4- yl)methoxy)piperidin-1-yl)phenyl)-3,5- dioxo-2,3,4,5-tetrahydro-1,2,4-triazine- 6-carbonitrile RNA-binding protein FXR1 [244-476] Homo sapiens 9.10 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665646 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665646&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902552 497615812 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400546 Fc1cccc(F)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(-9.75,-3,;-8.23,-3.27,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.3,-2.05,;-7.81,-.59,;-9.28,-.12,;-9.28,1.42,;-7.81,1.9,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;-6.91,.65,;-5.37,.66,;-4.6,1.99,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C26H24F2N4O4/c27-20-2-1-3-21(28)22(20)23-19(24(35-30-23)15-4-5-15)14-34-18-10-12-32(13-11-18)17-8-6-16(7-9-17)25-29-26(33)36-31-25/h1-3,6-9,15,18H,4-5,10-14H2,(H,29,31,33) WGHULKPZVMZGLT-UHFFFAOYSA-N 665647 US20240116912, Example 26::3-(4-(4-((5-cyclopropyl-3-(2,6- difluorophenyl)isoxazol-4- yl)methoxy)piperidin-1-yl)phenyl)- 1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 111 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665647 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665647&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902553 497615813 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400547 CCOc1cccc(F)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(-2.78,-2.93,;-3.22,-1.46,;-4.72,-1.11,;-5.78,-2.24,;-5.18,-3.66,;-6.11,-4.88,;-7.64,-4.69,;-8.23,-3.27,;-9.75,-3,;-7.3,-2.05,;-7.81,-.59,;-9.28,-.12,;-9.28,1.42,;-7.81,1.9,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;-6.91,.65,;-5.37,.66,;-4.6,1.99,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C28H29FN4O5/c1-2-35-23-5-3-4-22(29)24(23)25-21(26(37-31-25)17-6-7-17)16-36-20-12-14-33(15-13-20)19-10-8-18(9-11-19)27-30-28(34)38-32-27/h3-5,8-11,17,20H,2,6-7,12-16H2,1H3,(H,30,32,34) VITPRUSENBCRQP-UHFFFAOYSA-N 665648 US20240116912, Example 27::3-(4-(4-((5-cyclopropyl-3-(2-ethoxy-6- fluorophenyl)isoxazol-4- yl)methoxy)piperidin-1-yl)phenyl)- 1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 227 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665648&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902554 497615814 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400548 COc1cccc(F)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(-3.22,-1.46,;-4.72,-1.11,;-5.78,-2.24,;-5.18,-3.66,;-6.11,-4.88,;-7.64,-4.69,;-8.23,-3.27,;-9.75,-3,;-7.3,-2.05,;-7.81,-.59,;-9.28,-.12,;-9.28,1.42,;-7.81,1.9,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;-6.91,.65,;-5.37,.66,;-4.6,1.99,;-3.06,2.02,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C27H27FN4O5/c1-34-22-4-2-3-21(28)23(22)24-20(25(36-30-24)16-5-6-16)15-35-19-11-13-32(14-12-19)18-9-7-17(8-10-18)26-29-27(33)37-31-26/h2-4,7-10,16,19H,5-6,11-15H2,1H3,(H,29,31,33) AVYPINKXTZNOIU-UHFFFAOYSA-N 665649 US20240116912, Example 28::3-(4-(4-((5-cyclopropyl-3-(2-fluoro-6- methoxyphenyl)isoxazol-4- yl)methoxy)piperidin-1-yl)phenyl)- 1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 150 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665649 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665649&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902555 497615815 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400549 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1nc(co1)-c1noc(=O)[nH]1 |(3.05,3.34,;3.8,4.69,;3.03,6.02,;3.8,7.36,;5.34,7.36,;6.11,6.02,;7.65,6.02,;5.34,4.69,;6.12,3.36,;7.65,3.2,;7.97,1.7,;6.64,.93,;6.46,-.6,;5.56,-1.85,;7.09,-2.01,;5.49,1.96,;3.99,1.63,;3.51,.17,;2.03,-.23,;.94,.86,;-.55,.46,;-.95,-1.03,;.14,-2.12,;1.63,-1.72,;-2.44,-1.43,;-3.16,-2.79,;-4.68,-2.51,;-4.89,-.99,;-3.5,-.32,;-5.73,-3.64,;-7.24,-3.37,;-7.97,-4.73,;-6.9,-5.84,;-7.15,-7.36,;-5.52,-5.17,)| InChI=1S/C23H21Cl2N5O5/c24-15-2-1-3-16(25)18(15)19-14(20(34-28-19)12-4-5-12)10-32-13-6-8-30(9-7-13)22-26-17(11-33-22)21-27-23(31)35-29-21/h1-3,11-13H,4-10H2,(H,27,29,31) AOZVHVRKPWPEAS-UHFFFAOYSA-N 665650 US20240116912, Example 29::3-(2-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)oxazol-4-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 231 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665650 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665650&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902556 497615816 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400550 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1csc(c1)-c1noc(=O)[nH]1 |(3.08,3.3,;3.82,4.65,;3.05,5.98,;3.82,7.32,;5.36,7.32,;6.13,5.98,;7.67,5.98,;5.36,4.65,;6.14,3.32,;7.68,3.16,;8,1.65,;6.66,.88,;6.49,-.65,;5.58,-1.89,;7.11,-2.06,;5.52,1.91,;4.01,1.59,;3.54,.12,;2.05,-.27,;.96,.82,;-.52,.42,;-.92,-1.07,;.17,-2.16,;1.65,-1.76,;-2.46,-1.38,;-3.53,-.27,;-4.91,-.95,;-4.7,-2.47,;-3.19,-2.74,;-5.75,-3.6,;-7.27,-3.33,;-8,-4.69,;-6.93,-5.8,;-7.18,-7.32,;-5.54,-5.12,)| InChI=1S/C24H22Cl2N4O4S/c25-17-2-1-3-18(26)20(17)21-16(22(33-28-21)13-4-5-13)11-32-15-6-8-30(9-7-15)14-10-19(35-12-14)23-27-24(31)34-29-23/h1-3,10,12-13,15H,4-9,11H2,(H,27,29,31) ZVJUJDFTCRPQFP-UHFFFAOYSA-N 665651 US20240116912, Example 30::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)thiophen-2-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 296 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665651&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902557 497615817 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400551 C[C@@H]1CN(CC[C@@H]1OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |r,wU:6.7,1.0,(-3.06,-.65,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-33(18-9-7-17(8-10-18)26-30-27(34)37-32-26)12-11-22(15)35-14-19-24(31-36-25(19)16-5-6-16)23-20(28)3-2-4-21(23)29/h2-4,7-10,15-16,22H,5-6,11-14H2,1H3,(H,30,32,34) VGLOGNKYXIRKHR-UHFFFAOYSA-N 665652 US20240116912, Example 31::3-(4-((3R,4S)-4-((5-cyclopropyl-3-(2,6- dichlorophenyl)isoxazol-4- yl)methoxy)-3-methylpiperidin-1- yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 45.0 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665652 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665652&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902558 497615818 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400552 C[C@H]1CN(CC[C@H]1OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |r,wD:6.7,1.0,(-3.06,-.65,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-33(18-9-7-17(8-10-18)26-30-27(34)37-32-26)12-11-22(15)35-14-19-24(31-36-25(19)16-5-6-16)23-20(28)3-2-4-21(23)29/h2-4,7-10,15-16,22H,5-6,11-14H2,1H3,(H,30,32,34) VGLOGNKYXIRKHR-UHFFFAOYSA-N 665653 US20240116912, Example 32::3-(4-((3S,4R)-4-((5-cyclopropyl-3-(2,6- dichlorophenyl)isoxazol-4- yl)methoxy)-3-methylpiperidin-1- yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 12.6 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665653&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902559 497615819 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400553 C[C@H]1CN(CC[C@@H]1OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |r,wU:6.7,wD:1.0,(-3.06,-.65,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-33(18-9-7-17(8-10-18)26-30-27(34)37-32-26)12-11-22(15)35-14-19-24(31-36-25(19)16-5-6-16)23-20(28)3-2-4-21(23)29/h2-4,7-10,15-16,22H,5-6,11-14H2,1H3,(H,30,32,34) VGLOGNKYXIRKHR-UHFFFAOYSA-N 665654 US20240116912, Example 33::3-(4-((3S,4S)-4-((5-cyclopropyl-3-(2,6- dichlorophenyl)isoxazol-4- yl)methoxy)-3-methylpiperidin-1- yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 142 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665654 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665654&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902560 497615820 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400554 C[C@@H]1CN(CC[C@H]1OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |r,wU:1.0,wD:6.7,(-3.06,-.65,;-2.29,.69,;-.75,.69,;.02,2.02,;-.75,3.35,;-2.29,3.35,;-3.06,2.02,;-4.6,1.99,;-5.37,.66,;-6.91,.65,;-7.81,1.9,;-9.28,1.42,;-9.28,-.12,;-7.81,-.59,;-7.3,-2.05,;-8.23,-3.27,;-9.75,-3,;-7.64,-4.69,;-6.11,-4.88,;-5.18,-3.66,;-5.78,-2.24,;-4.72,-1.11,;-7.36,3.37,;-7.66,4.88,;-6.21,4.39,;1.56,2.02,;2.33,3.35,;3.87,3.35,;4.64,2.02,;3.87,.69,;2.33,.69,;6.18,2.02,;7.09,3.26,;8.55,2.79,;8.55,1.25,;9.75,.28,;7.09,.77,)| InChI=1S/C27H26Cl2N4O4/c1-15-13-33(18-9-7-17(8-10-18)26-30-27(34)37-32-26)12-11-22(15)35-14-19-24(31-36-25(19)16-5-6-16)23-20(28)3-2-4-21(23)29/h2-4,7-10,15-16,22H,5-6,11-14H2,1H3,(H,30,32,34) VGLOGNKYXIRKHR-UHFFFAOYSA-N 665655 US20240116912, Example 34::3-(4-((3R,4R)-4-((5-cyclopropyl-3- (2,6-dichlorophenyl)isoxazol-4- yl)methoxy)-3-methylpiperidin-1- yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 153 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665655 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665655&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902561 497615821 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400555 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(s1)-c1noc(=O)[nH]1 |(2.99,3.28,;3.74,4.62,;2.97,5.96,;3.74,7.29,;5.28,7.29,;6.05,5.96,;7.59,5.96,;5.28,4.62,;6.06,3.3,;7.59,3.14,;7.91,1.63,;6.58,.86,;6.41,-.67,;5.5,-1.92,;7.04,-2.08,;5.43,1.89,;3.93,1.55,;3.45,.08,;1.94,-.2,;1.45,-1.66,;-.07,-1.96,;-1.08,-.8,;-.59,.66,;.92,.96,;-2.6,-1.06,;-3.74,-.03,;-5.08,-.8,;-4.76,-2.31,;-3.22,-2.47,;-5.75,-3.48,;-7.29,-3.32,;-7.91,-4.73,;-6.77,-5.76,;-6.92,-7.29,;-5.43,-4.99,)| InChI=1S/C24H22Cl2N4O4S/c25-16-2-1-3-17(26)20(16)21-15(22(33-28-21)13-4-5-13)12-32-14-8-10-30(11-9-14)19-7-6-18(35-19)23-27-24(31)34-29-23/h1-3,6-7,13-14H,4-5,8-12H2,(H,27,29,31) IBNFFGOEIFCRTL-UHFFFAOYSA-N 665656 US20240116912, Example 35::3-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)thiophen-2-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 43.5 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665656&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902562 497615822 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400556 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 InChI=1S/C27H25F3N4O5/c28-27(29,30)37-22-4-2-1-3-20(22)23-21(24(38-32-23)16-5-6-16)15-36-19-11-13-34(14-12-19)18-9-7-17(8-10-18)25-31-26(35)39-33-25/h1-4,7-10,16,19H,5-6,11-15H2,(H,31,33,35) DPFJJVPFDCVGAN-UHFFFAOYSA-N 665657 US20240116912, Example 36::3-(4-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 18.8 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665657&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902563 497615823 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400557 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1n[nH]c(=O)o1 |(4.67,1.2,;5.39,2.56,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;6.93,2.56,;7.68,1.22,;9.22,1.06,;9.54,-.45,;8.2,-1.22,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;7.06,-.18,;5.55,-.5,;5.07,-1.97,;3.53,-2.25,;2.99,-3.69,;1.47,-3.93,;.49,-2.74,;1.04,-1.3,;2.56,-1.05,;-1.02,-3.01,;-2,-1.82,;-3.52,-2.06,;-4.06,-3.5,;-3.09,-4.7,;-1.57,-4.45,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,)| InChI=1S/C25H23Cl2N5O4/c26-18-2-1-3-19(27)21(18)22-17(23(36-31-22)14-4-5-14)13-34-16-8-10-32(11-9-16)20-7-6-15(12-28-20)24-29-30-25(33)35-24/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,30,33) AXNNQHZFZVRSJV-UHFFFAOYSA-N 665658 US20240116912, Example 37::5-(6-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 49.4 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665658&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566662 497615824 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400558 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1cc(cs1)-c1noc(=O)[nH]1 |(4.29,.93,;5.03,2.28,;4.26,3.61,;5.03,4.95,;6.57,4.95,;7.34,3.61,;8.88,3.61,;6.57,2.28,;7.34,.94,;8.87,.78,;9.19,-.73,;7.85,-1.5,;7.67,-3.02,;6.78,-4.28,;8.32,-4.42,;6.71,-.47,;5.21,-.81,;4.7,-2.26,;3.2,-2.66,;2.71,-4.12,;1.19,-4.41,;.18,-3.25,;.68,-1.8,;2.19,-1.5,;-1.33,-3.55,;-2.46,-2.5,;-3.8,-3.25,;-3.51,-4.76,;-1.98,-4.95,;-5.23,-2.66,;-5.52,-1.15,;-7.05,-.96,;-7.7,-2.36,;-9.19,-2.76,;-6.57,-3.41,)| InChI=1S/C24H22Cl2N4O4S/c25-17-2-1-3-18(26)20(17)21-16(22(33-28-21)13-4-5-13)11-32-15-6-8-30(9-7-15)19-10-14(12-35-19)23-27-24(31)34-29-23/h1-3,10,12-13,15H,4-9,11H2,(H,27,29,31) UURWNSVUOBAODZ-UHFFFAOYSA-N 665659 US20240116912, Example 38::3-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)thiophen-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 28.6 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665659 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665659&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902564 497615825 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400559 Fc1cc(ccc1N1CCC(CC1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1)-c1noc(=O)[nH]1 |(-1.45,-.38,;-2,-1.82,;-3.52,-2.06,;-4.06,-3.5,;-3.09,-4.7,;-1.57,-4.45,;-1.02,-3.01,;.49,-2.74,;1.47,-3.93,;2.99,-3.69,;3.53,-2.25,;2.56,-1.05,;1.04,-1.3,;5.07,-1.97,;5.55,-.5,;7.06,-.18,;8.2,-1.22,;9.54,-.45,;9.22,1.06,;7.68,1.22,;6.93,2.56,;5.39,2.56,;4.67,1.2,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,)| InChI=1S/C26H23Cl2FN4O4/c27-18-2-1-3-19(28)22(18)23-17(24(36-31-23)14-4-5-14)13-35-16-8-10-33(11-9-16)21-7-6-15(12-20(21)29)25-30-26(34)37-32-25/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,30,32,34) GHPVMVBXDLJGGQ-UHFFFAOYSA-N 665660 US20240116912, Example 39::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-3-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 16.1 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665660&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902565 497615826 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400560 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(nc1)-c1n[nH]c(=O)o1 |(4.67,1.2,;5.39,2.56,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;6.93,2.56,;7.68,1.22,;9.22,1.06,;9.54,-.45,;8.2,-1.22,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;7.06,-.18,;5.55,-.5,;5.07,-1.97,;3.53,-2.25,;2.99,-3.69,;1.47,-3.93,;.49,-2.74,;1.04,-1.3,;2.56,-1.05,;-1.02,-3.01,;-2,-1.82,;-3.52,-2.06,;-4.06,-3.5,;-3.09,-4.7,;-1.57,-4.45,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,)| InChI=1S/C25H23Cl2N5O4/c26-18-2-1-3-19(27)21(18)22-17(23(36-31-22)14-4-5-14)13-34-16-8-10-32(11-9-16)15-6-7-20(28-12-15)24-29-30-25(33)35-24/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,30,33) CORBMDRAWBJYLO-UHFFFAOYSA-N 665661 US20240116912, Example 40::5-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-2-yl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 76.0 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665661 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665661&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566661 497615827 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400561 Fc1cc(ccc1-c1n[nH]c(=O)[nH]c1=O)N1CCC(CC1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |(-4.14,-.72,;-3.15,-1.89,;-1.62,-1.71,;-.69,-2.94,;-1.3,-4.35,;-2.83,-4.54,;-3.75,-3.31,;-5.27,-3.56,;-5.87,-4.98,;-7.4,-5.16,;-8.33,-3.93,;-9.84,-4.24,;-7.73,-2.52,;-6.2,-2.33,;-5.63,-.9,;.83,-2.75,;1.76,-3.98,;3.29,-3.79,;3.89,-2.38,;2.97,-1.15,;1.44,-1.33,;5.39,-2.06,;5.86,-.59,;7.36,-.24,;8.51,-1.27,;9.84,-.5,;9.52,1.01,;7.99,1.17,;7.21,2.5,;5.67,2.5,;4.96,1.13,;4.9,3.83,;5.67,5.16,;7.21,5.16,;7.98,3.83,;9.52,3.83,;8.31,-2.8,;7.42,-4.05,;8.96,-4.2,)| InChI=1S/C27H24Cl2FN5O4/c28-19-2-1-3-20(29)22(19)23-18(25(39-34-23)14-4-5-14)13-38-16-8-10-35(11-9-16)15-6-7-17(21(30)12-15)24-26(36)31-27(37)33-32-24/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H2,31,33,36,37) JSBWPOVCEZGKMW-UHFFFAOYSA-N 665662 US20240116912, Example 41::6-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-2-fluorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 58.4 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665662 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665662&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902566 497615828 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400562 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1cc(on1)-c1noc(=O)[nH]1 |(4.29,.93,;5.03,2.28,;4.26,3.61,;5.03,4.95,;6.57,4.95,;7.34,3.61,;8.88,3.61,;6.57,2.28,;7.34,.94,;8.87,.78,;9.19,-.73,;7.85,-1.5,;7.67,-3.02,;6.78,-4.28,;8.32,-4.42,;6.71,-.47,;5.21,-.81,;4.7,-2.26,;3.2,-2.66,;2.71,-4.12,;1.19,-4.41,;.18,-3.25,;.68,-1.8,;2.19,-1.5,;-1.33,-3.55,;-2.46,-2.5,;-3.8,-3.25,;-3.51,-4.76,;-1.98,-4.95,;-5.23,-2.66,;-5.52,-1.15,;-7.05,-.96,;-7.7,-2.36,;-9.19,-2.76,;-6.57,-3.41,)| InChI=1S/C23H21Cl2N5O5/c24-15-2-1-3-16(25)19(15)20-14(21(34-28-20)12-4-5-12)11-32-13-6-8-30(9-7-13)18-10-17(33-27-18)22-26-23(31)35-29-22/h1-3,10,12-13H,4-9,11H2,(H,26,29,31) AXABLBLDSZVVQT-UHFFFAOYSA-N 665663 US20240116912, Example 42::3-(3-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)isoxazol-5-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 139 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665663&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902567 497615829 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400563 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1n[nH]c(=O)[nH]c1=O |(4.96,1.13,;5.67,2.5,;4.9,3.83,;5.67,5.16,;7.21,5.16,;7.98,3.83,;9.52,3.83,;7.21,2.5,;7.99,1.17,;9.52,1.01,;9.84,-.5,;8.51,-1.27,;8.31,-2.8,;7.42,-4.05,;8.96,-4.2,;7.36,-.24,;5.86,-.59,;5.39,-2.06,;3.89,-2.38,;3.29,-3.79,;1.76,-3.98,;.83,-2.75,;1.44,-1.33,;2.97,-1.15,;-.69,-2.94,;-1.62,-1.71,;-3.15,-1.89,;-3.75,-3.31,;-2.83,-4.54,;-1.3,-4.35,;-5.27,-3.56,;-5.87,-4.98,;-7.4,-5.16,;-8.33,-3.93,;-9.84,-4.24,;-7.73,-2.52,;-6.2,-2.33,;-5.63,-.9,)| InChI=1S/C26H24Cl2N6O4/c27-18-2-1-3-19(28)21(18)23-17(24(38-33-23)14-4-5-14)13-37-16-8-10-34(11-9-16)20-7-6-15(12-29-20)22-25(35)30-26(36)32-31-22/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H2,30,32,35,36) AMAUCSHHMGEUTN-UHFFFAOYSA-N 665664 US20240116912, Example 43::6-(6-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)-1,2,4-triazine-3, 5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 11.2 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665664&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902568 497615830 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400564 Clc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 InChI=1S/C26H25ClN4O4/c27-22-4-2-1-3-20(22)23-21(24(34-29-23)16-5-6-16)15-33-19-11-13-31(14-12-19)18-9-7-17(8-10-18)25-28-26(32)35-30-25/h1-4,7-10,16,19H,5-6,11-15H2,(H,28,30,32) UMYXAJFONPTXOV-UHFFFAOYSA-N 665665 US20240116912, Example 44::3-(4-(4-((3-(2-chlorophenyl)-5-cyclopropylisoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 21.3 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665665&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902569 497615831 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400565 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1nc(n[nH]1)-c1noc(=O)[nH]1 |(4.29,.93,;5.03,2.28,;4.26,3.61,;5.03,4.95,;6.57,4.95,;7.34,3.61,;8.88,3.61,;6.57,2.28,;7.34,.94,;8.87,.78,;9.19,-.73,;7.85,-1.5,;7.67,-3.02,;6.78,-4.28,;8.32,-4.42,;6.71,-.47,;5.21,-.81,;4.7,-2.26,;3.2,-2.66,;2.71,-4.12,;1.19,-4.41,;.18,-3.25,;.68,-1.8,;2.19,-1.5,;-1.33,-3.55,;-2.46,-2.5,;-3.8,-3.25,;-3.51,-4.76,;-1.98,-4.95,;-5.23,-2.66,;-5.52,-1.15,;-7.05,-.96,;-7.7,-2.36,;-9.19,-2.76,;-6.57,-3.41,)| InChI=1S/C22H21Cl2N7O4/c23-14-2-1-3-15(24)16(14)17-13(18(34-29-17)11-4-5-11)10-33-12-6-8-31(9-7-12)21-25-19(27-28-21)20-26-22(32)35-30-20/h1-3,11-12H,4-10H2,(H,25,27,28)(H,26,30,32) WCFORUILDDQCFE-UHFFFAOYSA-N 665666 US20240116912, Example 45::3-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-1H-1,2,4-triazol-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 610 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665666&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902570 497615832 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400566 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(nc1)-c1n[nH]c(=O)[nH]c1=O |(4.96,1.13,;5.67,2.5,;4.9,3.83,;5.67,5.16,;7.21,5.16,;7.98,3.83,;9.52,3.83,;7.21,2.5,;7.99,1.17,;9.52,1.01,;9.84,-.5,;8.51,-1.27,;8.31,-2.8,;7.42,-4.05,;8.96,-4.2,;7.36,-.24,;5.86,-.59,;5.39,-2.06,;3.89,-2.38,;3.29,-3.79,;1.76,-3.98,;.83,-2.75,;1.44,-1.33,;2.97,-1.15,;-.69,-2.94,;-1.62,-1.71,;-3.15,-1.89,;-3.75,-3.31,;-2.83,-4.54,;-1.3,-4.35,;-5.27,-3.56,;-5.87,-4.98,;-7.4,-5.16,;-8.33,-3.93,;-9.84,-4.24,;-7.73,-2.52,;-6.2,-2.33,;-5.63,-.9,)| InChI=1S/C26H24Cl2N6O4/c27-18-2-1-3-19(28)21(18)22-17(24(38-33-22)14-4-5-14)13-37-16-8-10-34(11-9-16)15-6-7-20(29-12-15)23-25(35)30-26(36)32-31-23/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H2,30,32,35,36) DCKSWSDGNMVUQY-UHFFFAOYSA-N 665667 US20240116912, Example 46::6-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-2-yl)-1,2,4-triazine-3, 5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 74.6 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665667&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902571 497615833 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400567 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 InChI=1S/C28H27F3N4O5/c29-28(30,31)38-23-6-2-1-5-21(23)24-22(25(39-33-24)17-7-8-17)16-37-20-4-3-14-35(15-13-20)19-11-9-18(10-12-19)26-32-27(36)40-34-26/h1-2,5-6,9-12,17,20H,3-4,7-8,13-16H2,(H,32,34,36) VLYBNKUTHOFPGK-UHFFFAOYSA-N 665668 US20240116912, Example 47::3-(4-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)azepan-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3.70 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665668&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902572 497615834 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400568 Fc1cc(ccc1-c1n[nH]c(=O)o1)N1CCC(CC1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |(-4.49,-.87,;-3.52,-2.06,;-2,-1.82,;-1.02,-3.01,;-1.57,-4.45,;-3.09,-4.7,;-4.06,-3.5,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,;.49,-2.74,;1.47,-3.93,;2.99,-3.69,;3.53,-2.25,;2.56,-1.05,;1.04,-1.3,;5.07,-1.97,;5.55,-.5,;7.06,-.18,;8.2,-1.22,;9.54,-.45,;9.22,1.06,;7.68,1.22,;6.93,2.56,;5.39,2.56,;4.67,1.2,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;8.04,-2.75,;7.14,-4,;8.67,-4.15,)| InChI=1S/C26H23Cl2FN4O4/c27-19-2-1-3-20(28)22(19)23-18(24(37-32-23)14-4-5-14)13-35-16-8-10-33(11-9-16)15-6-7-17(21(29)12-15)25-30-31-26(34)36-25/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,31,34) PXBRADODGVCPRN-UHFFFAOYSA-N 665669 US20240116912, Example 48::5-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-2-fluorophenyl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 41.6 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665669&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566588 497615835 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400569 Fc1cccc(F)c1-c1noc(C2CC2)c1COC1CCCN(CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(8.56,6.11,;7.02,6.11,;6.25,7.44,;4.71,7.44,;3.94,6.11,;4.71,4.77,;3.94,3.44,;6.25,4.77,;7.05,3.46,;8.58,3.3,;8.9,1.79,;7.57,1.02,;7.41,-.51,;6.5,-1.76,;8.04,-1.92,;6.43,2.05,;4.93,1.68,;4.46,.21,;2.96,-.11,;2,1.1,;.46,1.1,;-.5,-.11,;-.16,-1.61,;1.23,-2.28,;2.61,-1.61,;-1.37,-2.56,;-2.79,-1.96,;-4.02,-2.9,;-3.83,-4.42,;-2.41,-5.02,;-1.18,-4.09,;-5,-5.43,;-5,-6.97,;-6.46,-7.44,;-7.36,-6.2,;-8.9,-6.2,;-6.46,-4.95,)| InChI=1S/C27H26F2N4O4/c28-21-4-1-5-22(29)23(21)24-20(25(36-31-24)16-6-7-16)15-35-19-3-2-13-33(14-12-19)18-10-8-17(9-11-18)26-30-27(34)37-32-26/h1,4-5,8-11,16,19H,2-3,6-7,12-15H2,(H,30,32,34) DZRCSJBJJXIZEP-UHFFFAOYSA-N 665670 US20240116912, Example 49::3-(4-(4-((5-cyclopropyl-3-(2,6-difluorophenyl)isoxazol-4-yl)methoxy)azepan-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 11.7 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665670&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902573 497615836 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400570 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1CO[C@@H]1C[C@@H]2CC[C@H](C1)N2c1ccc(cc1)-c1noc(=O)[nH]1 |r,TLB:29:28:24.25:22.27.21| InChI=1S/C29H27F3N4O5/c30-29(31,32)39-24-4-2-1-3-22(24)25-23(26(40-34-25)16-5-6-16)15-38-21-13-19-11-12-20(14-21)36(19)18-9-7-17(8-10-18)27-33-28(37)41-35-27/h1-4,7-10,16,19-21H,5-6,11-15H2,(H,33,35,37) BYAFZEYXTSSODB-UHFFFAOYSA-N 665671 US20240116912, Example 50::3-(4-((1R,F,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3.20 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665671&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902574 497615837 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400571 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1n[nH]c(=O)o1 InChI=1S/C27H25F3N4O5/c28-27(29,30)38-22-4-2-1-3-20(22)23-21(24(39-33-23)16-5-6-16)15-36-19-11-13-34(14-12-19)18-9-7-17(8-10-18)25-31-32-26(35)37-25/h1-4,7-10,16,19H,5-6,11-15H2,(H,32,35) NKHHFBDVLNHMQZ-UHFFFAOYSA-N 665672 US20240116912, Example 51::5-(4-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 325 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665672 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665672&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566705 497615838 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400572 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1cc(=O)[nH]o1 InChI=1S/C28H26F3N3O5/c29-28(30,31)37-23-4-2-1-3-21(23)26-22(27(39-33-26)18-5-6-18)16-36-20-11-13-34(14-12-20)19-9-7-17(8-10-19)24-15-25(35)32-38-24/h1-4,7-10,15,18,20H,5-6,11-14,16H2,(H,32,35) XZLIABHJTOJOSF-UHFFFAOYSA-N 665673 US20240116912, Example 52::5-(4-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)isoxazol-3(2H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 143 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665673&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566686 497615839 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400573 FC1(F)CN(CCC1OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1)c1ccc(cc1)-c1noc(=O)[nH]1 |(4.47,-3.29,;2.99,-3.69,;4.07,-4.78,;1.47,-3.93,;.49,-2.74,;1.04,-1.3,;2.56,-1.05,;3.53,-2.25,;5.07,-1.97,;5.55,-.5,;7.06,-.18,;8.2,-1.22,;9.54,-.45,;9.22,1.06,;7.68,1.22,;6.93,2.56,;5.39,2.56,;4.67,1.2,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;-1.02,-3.01,;-1.57,-4.45,;-3.09,-4.7,;-4.06,-3.5,;-3.52,-2.06,;-2,-1.82,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,)| InChI=1S/C26H22Cl2F2N4O4/c27-18-2-1-3-19(28)21(18)22-17(23(37-32-22)14-4-5-14)12-36-20-10-11-34(13-26(20,29)30)16-8-6-15(7-9-16)24-31-25(35)38-33-24/h1-3,6-9,14,20H,4-5,10-13H2,(H,31,33,35) IJLJJWISOXCVDC-UHFFFAOYSA-N 665674 US20240116912, Example 53::3-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-3,3-difluoropiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 9.00 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665674 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665674&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902575 497615840 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400574 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1(F)F)c1ccc(cc1)-c1noc(=O)[nH]1 InChI=1S/C27H23F5N4O5/c28-26(29)14-36(17-9-7-16(8-10-17)24-33-25(37)41-35-24)12-11-21(26)38-13-19-22(34-40-23(19)15-5-6-15)18-3-1-2-4-20(18)39-27(30,31)32/h1-4,7-10,15,21H,5-6,11-14H2,(H,33,35,37) VJGAIFWFJRSFMN-UHFFFAOYSA-N 665675 US20240116912, Example 54::3-(4-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-3,3-difluoropiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 37.6 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665675&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902576 497615841 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400575 Fc1cccc(F)c1-c1noc(C2CC2)c1COC1CCN(CC1(F)F)c1ccc(cc1)-c1noc(=O)[nH]1 |(4.67,1.2,;5.39,2.56,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;6.93,2.56,;7.68,1.22,;9.22,1.06,;9.54,-.45,;8.2,-1.22,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;7.06,-.18,;5.55,-.5,;5.07,-1.97,;3.53,-2.25,;2.56,-1.05,;1.04,-1.3,;.49,-2.74,;1.47,-3.93,;2.99,-3.69,;4.47,-3.29,;4.07,-4.78,;-1.02,-3.01,;-1.57,-4.45,;-3.09,-4.7,;-4.06,-3.5,;-3.52,-2.06,;-2,-1.82,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,)| InChI=1S/C26H22F4N4O4/c27-18-2-1-3-19(28)21(18)22-17(23(37-32-22)14-4-5-14)12-36-20-10-11-34(13-26(20,29)30)16-8-6-15(7-9-16)24-31-25(35)38-33-24/h1-3,6-9,14,20H,4-5,10-13H2,(H,31,33,35) OYWBXAAJMNNSHC-UHFFFAOYSA-N 665676 US20240116912, Example 55::3-(4-(4-((5-cyclopropyl-3-(2,6-difluorophenyl)isoxazol-4-yl)methoxy)-3,3-difluoropiperidin-1-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 174 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665676 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665676&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902577 497615842 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400576 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1cnc(s1)-c1noc(=O)[nH]1 |(3.86,1.57,;5.07,2.53,;4.92,4.07,;6.18,4.96,;7.58,4.32,;7.72,2.79,;9.11,2.11,;6.47,1.89,;6.6,.36,;7.94,-.41,;7.62,-1.92,;6.09,-2.08,;5.33,-3.42,;4,-4.19,;5.33,-4.96,;5.46,-.67,;3.95,-.37,;3.18,-1.7,;1.68,-1.35,;.62,-2.46,;-.87,-2.11,;-1.31,-.63,;-.26,.49,;1.24,.13,;-2.82,-.3,;-3.56,1.05,;-5.07,.77,;-5.27,-.76,;-3.88,-1.42,;-6.66,-1.43,;-8.05,-.77,;-9.11,-1.88,;-8.37,-3.24,;-9.09,-4.6,;-6.85,-2.95,)| InChI=1S/C23H21Cl2N5O4S/c24-15-2-1-3-16(25)18(15)19-14(20(33-28-19)12-4-5-12)11-32-13-6-8-30(9-7-13)17-10-26-22(35-17)21-27-23(31)34-29-21/h1-3,10,12-13H,4-9,11H2,(H,27,29,31) VBPPFULYGPCZLP-UHFFFAOYSA-N 665677 US20240116912, Example 56::3-(5-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)thiazol-2-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 43.1 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665677&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902578 497615843 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400577 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-c1n[nH]c(=O)[nH]c1=O InChI=1S/C28H26F3N5O5/c29-28(30,31)40-22-4-2-1-3-20(22)24-21(25(41-35-24)17-5-6-17)15-39-19-11-13-36(14-12-19)18-9-7-16(8-10-18)23-26(37)32-27(38)34-33-23/h1-4,7-10,17,19H,5-6,11-15H2,(H2,32,34,37,38) DZNALYHLWBCSHI-UHFFFAOYSA-N 665678 US20240116912, Example 57::6-(4-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-triazine-3,5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 84.7 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665678 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665678&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902579 497615844 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400578 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1cc([nH]n1)-c1noc(=O)[nH]1 |(3.06,3.29,;3.8,4.64,;3.03,5.98,;3.8,7.31,;5.34,7.31,;6.11,5.98,;7.65,5.98,;5.34,4.64,;6.11,3.31,;7.64,3.15,;7.96,1.64,;6.63,.87,;6.44,-.66,;5.55,-1.92,;7.09,-2.06,;5.48,1.9,;3.98,1.56,;3.48,.11,;1.98,-.29,;1.48,-1.75,;-.03,-2.05,;-1.05,-.89,;-.55,.57,;.96,.87,;-2.56,-1.18,;-3.21,-2.58,;-4.73,-2.4,;-5.03,-.88,;-3.69,-.13,;-5.78,-3.52,;-7.31,-3.34,;-7.96,-4.73,;-6.83,-5.78,;-7.02,-7.31,;-5.49,-5.03,)| InChI=1S/C23H22Cl2N6O4/c24-15-2-1-3-16(25)19(15)20-14(21(34-29-20)12-4-5-12)11-33-13-6-8-31(9-7-13)18-10-17(27-28-18)22-26-23(32)35-30-22/h1-3,10,12-13H,4-9,11H2,(H,27,28)(H,26,30,32) SIFZRWFGQRCGDK-UHFFFAOYSA-N 665679 US20240116912, Example 58::3-(3-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-1H-pyrazol-5-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 421 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665679&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902580 497615845 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400579 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1cc(=O)[nH]o1 |(4.67,1.2,;5.39,2.56,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;6.93,2.56,;7.68,1.22,;9.22,1.06,;9.54,-.45,;8.2,-1.22,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;7.06,-.18,;5.55,-.5,;5.07,-1.97,;3.53,-2.25,;2.99,-3.69,;1.47,-3.93,;.49,-2.74,;1.04,-1.3,;2.56,-1.05,;-1.02,-3.01,;-2,-1.82,;-3.52,-2.06,;-4.06,-3.5,;-3.09,-4.7,;-1.57,-4.45,;-5.58,-3.8,;-6.76,-2.82,;-8.06,-3.64,;-9.54,-3.19,;-7.68,-5.13,;-6.15,-5.23,)| InChI=1S/C26H24Cl2N4O4/c27-19-2-1-3-20(28)24(19)25-18(26(36-31-25)15-4-5-15)14-34-17-8-10-32(11-9-17)22-7-6-16(13-29-22)21-12-23(33)30-35-21/h1-3,6-7,12-13,15,17H,4-5,8-11,14H2,(H,30,33) CRRSNVMAWCFTOP-UHFFFAOYSA-N 665680 US20240116912, Example 59::5-(6-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)isoxazol-3(2H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 17.9 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665680 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665680&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 167152080 497615846 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400580 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1cc(=O)[nH]o1 InChI=1S/C27H25F3N4O5/c28-27(29,30)37-21-4-2-1-3-19(21)25-20(26(39-33-25)16-5-6-16)15-36-18-9-11-34(12-10-18)23-8-7-17(14-31-23)22-13-24(35)32-38-22/h1-4,7-8,13-14,16,18H,5-6,9-12,15H2,(H,32,35) VVAUALOVFXRXNU-UHFFFAOYSA-N 665681 US20240116912, Example 60::5-(6-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)isoxazol-3(2H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 104 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665681&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566655 497615847 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400581 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1n[nH]c(=O)o1 InChI=1S/C26H24F3N5O5/c27-26(28,29)38-20-4-2-1-3-18(20)22-19(23(39-33-22)15-5-6-15)14-36-17-9-11-34(12-10-17)21-8-7-16(13-30-21)24-31-32-25(35)37-24/h1-4,7-8,13,15,17H,5-6,9-12,14H2,(H,32,35) HDMZNDFSNMUDFF-UHFFFAOYSA-N 665682 US20240116912, Example 61::5-(6-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 298 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665682&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 164566562 497615848 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400582 Clc1cccc(Cl)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cc1)-n1c(=O)cn[nH]c1=O |(9.57,2.8,;8.04,3.14,;7.58,4.61,;6.11,4.93,;5.11,3.82,;5.54,2.37,;4.52,1.12,;7.04,2,;7.53,.55,;8.97,.01,;8.97,-1.52,;7.55,-1.95,;7.02,-3.48,;7.33,-4.93,;5.94,-4.44,;6.62,-.72,;5.08,-.72,;4.29,-2.09,;2.75,-2.09,;1.98,-.75,;.44,-.75,;-.33,-2.09,;.44,-3.42,;1.98,-3.42,;-1.87,-2.09,;-2.64,-.75,;-4.18,-.75,;-4.95,-2.09,;-4.18,-3.42,;-2.64,-3.42,;-6.49,-2.09,;-7.26,-.75,;-6.49,.58,;-8.8,-.75,;-9.57,-2.09,;-8.8,-3.42,;-7.26,-3.42,;-6.49,-4.75,)| InChI=1S/C27H25Cl2N5O4/c28-21-2-1-3-22(29)24(21)25-20(26(38-32-25)16-4-5-16)15-37-19-10-12-33(13-11-19)17-6-8-18(9-7-17)34-23(35)14-30-31-27(34)36/h1-3,6-9,14,16,19H,4-5,10-13,15H2,(H,31,36) PUGWGSRCEWHMSC-UHFFFAOYSA-N 665683 US20240116912, Example 62::4-(4-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)phenyl)-1,2,4-triazine-3, 5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 6348 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665683&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902581 497615849 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400583 Fc1cccc(F)c1-c1noc(C2CC2)c1COC1CCN(CC1(F)F)c1ccc(cn1)-c1noc(=O)[nH]1 |(4.67,1.2,;5.39,2.56,;4.62,3.9,;5.39,5.23,;6.93,5.23,;7.7,3.9,;9.24,3.9,;6.93,2.56,;7.68,1.22,;9.22,1.06,;9.54,-.45,;8.2,-1.22,;8.04,-2.75,;7.14,-4,;8.67,-4.15,;7.06,-.18,;5.55,-.5,;5.07,-1.97,;3.53,-2.25,;2.56,-1.05,;1.04,-1.3,;.49,-2.74,;1.47,-3.93,;2.99,-3.69,;4.47,-3.29,;4.07,-4.78,;-1.02,-3.01,;-2,-1.82,;-3.52,-2.06,;-4.06,-3.5,;-3.09,-4.7,;-1.57,-4.45,;-5.58,-3.8,;-6.15,-5.23,;-7.68,-5.13,;-8.06,-3.64,;-9.54,-3.19,;-6.76,-2.82,)| InChI=1S/C25H21F4N5O4/c26-16-2-1-3-17(27)20(16)21-15(22(37-32-21)13-4-5-13)11-36-18-8-9-34(12-25(18,28)29)19-7-6-14(10-30-19)23-31-24(35)38-33-23/h1-3,6-7,10,13,18H,4-5,8-9,11-12H2,(H,31,33,35) SGUCWKQQFWWJKU-UHFFFAOYSA-N 665684 US20240116912, Example 63::3-(6-(4-((5-cyclopropyl-3-(2,6-difluorophenyl)isoxazol-4-yl)methoxy)-3,3-difluoropiperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 215 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665684&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902582 497615850 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400584 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1COC1CCN(CC1(F)F)c1ccc(cn1)-c1noc(=O)[nH]1 InChI=1S/C26H22F5N5O5/c27-25(28)13-36(20-8-7-15(11-32-20)23-33-24(37)41-35-23)10-9-19(25)38-12-17-21(34-40-22(17)14-5-6-14)16-3-1-2-4-18(16)39-26(29,30)31/h1-4,7-8,11,14,19H,5-6,9-10,12-13H2,(H,33,35,37) HYZQOPZFUOUPHQ-UHFFFAOYSA-N 665685 US20240116912, Example 64::3-(6-(4-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-3,3-difluoropiperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 70.0 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665685&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902583 497615851 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400585 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1CO[C@@H]1C[C@@H]2CC[C@H](C1)N2c1ccc(cc1)-c1n[nH]c(=O)o1 |r,TLB:29:28:24.25:22.27.21| InChI=1S/C29H27F3N4O5/c30-29(31,32)40-24-4-2-1-3-22(24)25-23(26(41-35-25)16-5-6-16)15-38-21-13-19-11-12-20(14-21)36(19)18-9-7-17(8-10-18)27-33-34-28(37)39-27/h1-4,7-10,16,19-21H,5-6,11-15H2,(H,34,37) DWHMYKVGOUDTOW-UHFFFAOYSA-N 665686 US20240116912, Example 65::5-(4-((1R,3R,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 22.1 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665686&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171420470 497615852 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400586 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1CO[C@@H]1C[C@@H]2CC[C@H](C1)N2c1ccc(cn1)-c1noc(=O)[nH]1 |r,TLB:29:28:24.25:22.27.21| InChI=1S/C28H26F3N5O5/c29-28(30,31)39-22-4-2-1-3-20(22)24-21(25(40-34-24)15-5-6-15)14-38-19-11-17-8-9-18(12-19)36(17)23-10-7-16(13-32-23)26-33-27(37)41-35-26/h1-4,7,10,13,15,17-19H,5-6,8-9,11-12,14H2,(H,33,35,37) YISIYHJCCDFFSR-UHFFFAOYSA-N 665687 US20240116912, Example 66::3-(6-((1R,3r,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 3.00 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665687&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902584 497615853 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400587 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1CO[C@@H]1C[C@@H]2CC[C@H](C1)N2c1ccc(cc1)-c1n[nH]c(=O)[nH]c1=O |r,TLB:29:28:24.25:22.27.21| InChI=1S/C30H28F3N5O5/c31-30(32,33)42-24-4-2-1-3-22(24)26-23(27(43-37-26)17-5-6-17)15-41-21-13-19-11-12-20(14-21)38(19)18-9-7-16(8-10-18)25-28(39)34-29(40)36-35-25/h1-4,7-10,17,19-21H,5-6,11-15H2,(H2,34,36,39,40) OAGWWMMZMMPWBJ-UHFFFAOYSA-N 665688 US20240116912, Example 67::6-(4-((1R,3R,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1,2,4-triazine-3,5(2H,4H)-dione RNA-binding protein FXR1 [244-476] Homo sapiens 12.7 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665688&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902585 497615854 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400588 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1CO[C@@H]1C[C@@H]2CC[C@H](C1)N2c1ccc(cn1)-c1n[nH]c(=O)o1 |r,TLB:29:28:24.25:22.27.21| InChI=1S/C28H26F3N5O5/c29-28(30,31)40-22-4-2-1-3-20(22)24-21(25(41-35-24)15-5-6-15)14-38-19-11-17-8-9-18(12-19)36(17)23-10-7-16(13-32-23)26-33-34-27(37)39-26/h1-4,7,10,13,15,17-19H,5-6,8-9,11-12,14H2,(H,34,37) YFLHDEJDOKGGSC-UHFFFAOYSA-N 665689 US20240116912, Example 68::5-(6-((1R,3R,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)pyridin-3-yl)-1,3,4-oxadiazol-2(3H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 26.4 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665689&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171420492 497615855 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400589 FC(F)(F)Oc1ccccc1-c1noc(C2CC2)c1CO[C@@H]1C[C@@H]2CC[C@H](C1)N2c1ccc(cn1)-c1cc(=O)[nH]o1 |r,TLB:29:28:24.25:22.27.21| InChI=1S/C29H27F3N4O5/c30-29(31,32)39-23-4-2-1-3-21(23)27-22(28(41-35-27)16-5-6-16)15-38-20-11-18-8-9-19(12-20)36(18)25-10-7-17(14-33-25)24-13-26(37)34-40-24/h1-4,7,10,13-14,16,18-20H,5-6,8-9,11-12,15H2,(H,34,37) CMNXAALLIGNTGC-UHFFFAOYSA-N 665690 US20240116912, Example 69::5-(6-((1R,3R,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)pyridin-3-yl)isoxazol-3(2H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 9.50 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665690 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665690&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171420472 497615856 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400590 Cn1nc(cc1-c1noc(=O)[nH]1)N1CCC(CC1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |(-6.55,-.59,;-5.1,-1.1,;-3.8,-.27,;-2.61,-1.25,;-3.18,-2.69,;-4.71,-2.59,;-5.65,-3.81,;-7.19,-3.71,;-7.76,-5.14,;-6.57,-6.13,;-6.67,-7.66,;-5.27,-5.3,;-1.12,-.87,;-.04,-1.97,;1.45,-1.59,;1.87,-.11,;.79,.99,;-.7,.61,;3.33,.45,;3.78,1.92,;5.28,2.26,;6.42,1.23,;7.76,2,;7.44,3.51,;5.9,3.67,;5.12,5,;3.58,5,;2.84,3.65,;2.81,6.33,;3.58,7.66,;5.12,7.66,;5.89,6.33,;7.43,6.33,;6.25,-.3,;5.33,-1.54,;6.86,-1.71,)| InChI=1S/C24H24Cl2N6O4/c1-31-18(23-27-24(33)36-30-23)11-19(28-31)32-9-7-14(8-10-32)34-12-15-21(29-35-22(15)13-5-6-13)20-16(25)3-2-4-17(20)26/h2-4,11,13-14H,5-10,12H2,1H3,(H,27,30,33) RMYKPSSUQWJVLJ-UHFFFAOYSA-N 665691 US20240116912, Example 70::3-(3-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)-1-methyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 233 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665691&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902586 497615857 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400591 C[C@@H]1C[C@@H](CCN1c1ccc(cn1)-c1noc(=O)[nH]1)OCc1c(onc1-c1c(Cl)cccc1Cl)C1CC1 |r,wU:3.21,1.0,(.06,4.72,;-.71,3.39,;-2.25,3.39,;-3.02,2.05,;-2.25,.72,;-.71,.72,;.06,2.05,;1.6,2.05,;2.37,.72,;3.91,.72,;4.68,2.05,;3.91,3.39,;2.37,3.39,;6.22,2.05,;7.12,3.3,;8.59,2.82,;8.59,1.28,;9.78,.3,;7.12,.81,;-4.56,2.02,;-5.33,.69,;-6.87,.69,;-7.78,1.93,;-9.24,1.46,;-9.24,-.08,;-7.78,-.56,;-7.27,-2.01,;-5.75,-2.3,;-4.72,-1.16,;-5.25,-3.75,;-6.25,-4.92,;-7.77,-4.63,;-8.27,-3.18,;-9.78,-2.85,;-7.33,3.41,;-7.62,4.92,;-6.17,4.42,)| InChI=1S/C26H25Cl2N5O4/c1-14-11-17(9-10-33(14)21-8-7-16(12-29-21)25-30-26(34)37-32-25)35-13-18-23(31-36-24(18)15-5-6-15)22-19(27)3-2-4-20(22)28/h2-4,7-8,12,14-15,17H,5-6,9-11,13H2,1H3,(H,30,32,34) HMBDUFHHADFDRE-UHFFFAOYSA-N 665692 US20240116912, Example 71::3-(6-((2R,4R)-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 2.10 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665692&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902587 497615858 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400592 C[C@@H]1C[C@@H](CCN1c1ccc(cn1)-c1noc(=O)[nH]1)OCc1c(onc1-c1ccccc1Cl)C1CC1 |r| InChI=1S/C26H26ClN5O4/c1-15-12-18(10-11-32(15)22-9-8-17(13-28-22)25-29-26(33)36-31-25)34-14-20-23(19-4-2-3-5-21(19)27)30-35-24(20)16-6-7-16/h2-5,8-9,13,15-16,18H,6-7,10-12,14H2,1H3,(H,29,31,33) LGFWNZZBWRDDGL-UHFFFAOYSA-N 665693 US20240116912, Example 72::3-(6-((2R,4R)-4-((3-(2-chlorophenyl)-5-cyclopropylisoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 4.50 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665693&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902588 497615859 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400593 C[C@@H]1C[C@@H](CCN1c1ccc(cn1)-c1noc(=O)[nH]1)OCc1c(onc1-c1c(F)cccc1F)C1CC1 |r,wU:3.21,1.0,(.06,4.72,;-.71,3.39,;-2.25,3.39,;-3.02,2.05,;-2.25,.72,;-.71,.72,;.06,2.05,;1.6,2.05,;2.37,.72,;3.91,.72,;4.68,2.05,;3.91,3.39,;2.37,3.39,;6.22,2.05,;7.12,3.3,;8.59,2.82,;8.59,1.28,;9.78,.3,;7.12,.81,;-4.56,2.02,;-5.33,.69,;-6.87,.69,;-7.78,1.93,;-9.24,1.46,;-9.24,-.08,;-7.78,-.56,;-7.27,-2.01,;-5.75,-2.3,;-4.72,-1.16,;-5.25,-3.75,;-6.25,-4.92,;-7.77,-4.63,;-8.27,-3.18,;-9.78,-2.85,;-7.33,3.41,;-7.62,4.92,;-6.17,4.42,)| InChI=1S/C26H25F2N5O4/c1-14-11-17(9-10-33(14)21-8-7-16(12-29-21)25-30-26(34)37-32-25)35-13-18-23(31-36-24(18)15-5-6-15)22-19(27)3-2-4-20(22)28/h2-4,7-8,12,14-15,17H,5-6,9-11,13H2,1H3,(H,30,32,34) KTYLPWGPWXPITR-UHFFFAOYSA-N 665694 US20240116912, Example 73::3-(6-((2R,4R)-4-((5-cyclopropyl-3-(2,6-difluorophenyl)isoxazol-4-yl)methoxy)-2-methylpiperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 47.6 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665694&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902589 497615860 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8 1400594 Fc1cccc(F)c1-c1noc(C2CC2)c1COC1CCN(CC1)c1ccc(cn1)-c1noc(=O)[nH]1 |(-4.72,-1.16,;-5.75,-2.3,;-5.25,-3.75,;-6.25,-4.92,;-7.77,-4.63,;-8.27,-3.18,;-9.78,-2.85,;-7.27,-2.01,;-7.78,-.56,;-9.24,-.08,;-9.24,1.46,;-7.78,1.93,;-7.33,3.41,;-7.62,4.92,;-6.17,4.42,;-6.87,.69,;-5.33,.69,;-4.56,2.02,;-3.02,2.05,;-2.25,.72,;-.71,.72,;.06,2.05,;-.71,3.39,;-2.25,3.39,;1.6,2.05,;2.37,.72,;3.91,.72,;4.68,2.05,;3.91,3.39,;2.37,3.39,;6.22,2.05,;7.12,3.3,;8.59,2.82,;8.59,1.28,;9.78,.3,;7.12,.81,)| InChI=1S/C25H23F2N5O4/c26-18-2-1-3-19(27)21(18)22-17(23(35-30-22)14-4-5-14)13-34-16-8-10-32(11-9-16)20-7-6-15(12-28-20)24-29-25(33)36-31-24/h1-3,6-7,12,14,16H,4-5,8-11,13H2,(H,29,31,33) LZORJYAULDARGP-UHFFFAOYSA-N 665695 US20240116912, Example 74::3-(6-(4-((5-cyclopropyl-3-(2,6-difluorophenyl)isoxazol-4-yl)methoxy)piperidin-1-yl)pyridin-3-yl)-1,2,4-oxadiazol-5(4H)-one RNA-binding protein FXR1 [244-476] Homo sapiens 107 US Patent 10.7270/Q23X8BX4 aid1963638 US20240116912 XU, Y; KLUCHER, K; ROMERO, FA 4/11/2024 6/29/2024 Terns Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=665695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1567&target=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=665695&enzyme=RNA-binding+protein+FXR1+%5B244-476%5D&column=ki&startPg=0&Increment=50&submit=Search 171902590 497615861 1 ARKVPGVTAIELDEDTGTFRIYGESADAVKKARGFLEFVEDFIQVPRNLVGKVIGKNGKVIQEIVDKSGVVRVRIEGDNENKLPREDGMVPFVFVGTKESIGNVQVLLEYHIAYLKEVEQLRMERLQIDEQLRQIGSRSYSGRGRGRRGPNYTSGYGTNSELSNPSETESERKDELSDWSLAGEDDRDSRHQRDSRRRPGGRGRSVSGGRGRGGPRGGKSSISSVLKDPDSNP 2CPQ RNA-binding protein FXR1 FXR1_HUMAN P51114 A8K9B8 Q7Z450 Q8N6R8